Found 1529 matching trials
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients
PHASE2Open label multicentric randomized phase II trial, using high throughput ge...
Location
Centre Hospitalier Henri Duffau
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
N/ALung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
PHASE2RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocki...
Location
University of Michigan Comprehensive Cancer Center
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
PHASE2This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Location
M D Anderson Cancer Center
Using ctDNA to Determine Therapies for Lung Cancer
PHASE2This is a study to look at whether the presence of circulating tumour DNA (...
Location
Princess Margaret Cancer Centre
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
PHASE2This is a single-center, open-label, phase I clinical trial aimed to evalua...
Location
Tianjin Medical University Cancer Institute and Hospital
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
PHASE1GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Location
GSK Investigational Site
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
PHASE2This is a prospective, multi-center, single arm study assessing the efficac...
Location
Henan Cancer Hospital
Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
PHASE1To determine the toxicities, maximum tolerated dose (MTD) and recommended p...
Location
Indiana University Cancer Center